{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:51:13Z","timestamp":1784127073795,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.ophtha.2005.02.020","type":"journal-article","created":{"date-parts":[[2005,7,31]],"date-time":"2005-07-31T08:02:09Z","timestamp":1122796929000},"page":"1472-1477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":180,"title":["Mycophenolate Mofetil Therapy for Inflammatory Eye Disease"],"prefix":"10.1016","volume":"112","author":[{"given":"Jennifer E.","family":"Thorne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faqir A.","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Kempen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2005.02.020_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.02.020_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","article-title":"Causes and frequency of blindness in patients with intraocular inflammatory disease","volume":"80","author":"Rothova","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.02.020_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000078612","article-title":"Uveitis","volume":"218","author":"Durrani","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2005.02.020_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.02.020_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.ophtha.2005.02.020_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00007890-200107150-00006","article-title":"Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation","volume":"72","author":"Sarwal","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ophtha.2005.02.020_bib7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1572-0241.2001.03622.x","article-title":"Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn\u2019s disease?","volume":"96","author":"Miehsler","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ophtha.2005.02.020_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1191\/096120301673517315","article-title":"Treatment of systemic lupus erythematosus with mycophenolate mofetil","volume":"10","author":"Adu","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.ophtha.2005.02.020_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.139.6.739","article-title":"Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil","volume":"139","author":"Mimouni","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2005.02.020_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1515\/CCLM.2000.191","article-title":"Pharmacodynamic monitoring of mycophenolate mofetil","volume":"38","author":"Budde","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ophtha.2005.02.020_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0014-4835(05)80138-1","article-title":"Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism","volume":"61","author":"Chanaud","year":"1995","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2005.02.020_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0161-6420(99)90078-7","article-title":"Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease","volume":"106","author":"Larkin","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.02.020_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0161-6420(03)00092-7","article-title":"Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders","volume":"110","author":"Baltatzis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.02.020_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0002-9394(02)01814-7","article-title":"Severe scleritis and urticarial lesions","volume":"134","author":"Thorne","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.02.020_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2001-14917","article-title":"Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid","volume":"218","author":"Zurdel","year":"2001","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.ophtha.2005.02.020_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0140-6736(05)79515-5","article-title":"Rescue therapy with mycophenolate mofetil in refractory uveitis","volume":"352","author":"Kilmartin","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2005.02.020_bib17","year":"2001"},{"key":"10.1016\/j.ophtha.2005.02.020_bib18","first-page":"88","article-title":"Statistics with Stata (updated for version 7)","author":"Hamilton","year":"2003"},{"key":"10.1016\/j.ophtha.2005.02.020_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ophtha.2005.02.020_bib20","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","article-title":"Mycophenolate mofetil for the treatment of scleritis","volume":"110","author":"Sen","year":"2003","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642005003362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642005003362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:50:24Z","timestamp":1758981024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642005003362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0161642005003362"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2005.02.020","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycophenolate Mofetil Therapy for Inflammatory Eye Disease","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2005.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}